Company intelligence / Profile preview

Helixor Heilmittel GmbH

Rosenfeld, Baden-Württemberg, Germanyhelixor.com ↗

Ownership: Private
Employees: ~100
Development stage: Commercial

Overview

Helixor’s mistletoe extracts are widely used in integrative oncology as adjunctive therapy. The company has over four decades of experience and its products comply with GMP standards. Clinical results focus on quality-of-life improvements for cancer patients using natural product-based therapies.

Therapeutic areas: Oncology
Modalities: Plant extracts (notably mistletoe extract)botanical medicines
Industry: Biotech

Drug pipeline

4 assets

viscum album

3 more assets in the full pipeline.

Request access →

Partnerships

No major pharmaceutical or biotech partnerships publicly listed

Beyond the preview

Go deeper on Helixor Heilmittel GmbH.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Helixor Heilmittel GmbH.

Explore the full profile